Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 4
2004 2
2005 11
2006 19
2007 18
2008 17
2009 27
2010 25
2011 24
2012 32
2013 44
2014 45
2015 43
2016 38
2017 42
2018 48
2019 40
2020 64
2021 72
2022 56
2023 55
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

662 results

Results by year

Filters applied: . Clear all
Page 1
Impact of neoadjuvant relugolix on patient-reported sexual function and bother.
Hsueh JY, Gallagher L, Koh MJ, Eden S, Shah S, Wells M, Danner M, Zwart A, Ayoob M, Kumar D, Leger P, Dawson NA, Suy S, Rubin R, Collins SP. Hsueh JY, et al. Among authors: collins sp. Front Oncol. 2024 Apr 11;14:1377103. doi: 10.3389/fonc.2024.1377103. eCollection 2024. Front Oncol. 2024. PMID: 38665954 Free PMC article.
Bothersome Hot Flashes Following Neoadjuvant Androgen Deprivation Therapy and Stereotactic Body Radiotherapy for Localized Prostate Cancer.
Shah S, Pepin A, Jatar S, Hsueh J, Gallagher L, Danner MT, Zwart A, Ayoob M, Yung TM, Kumar D, Aghdam N, Leger PD, Dawson NA, Simeng S, Collins SP. Shah S, et al. Among authors: collins sp. Cureus. 2024 Mar 7;16(3):e55729. doi: 10.7759/cureus.55729. eCollection 2024 Mar. Cureus. 2024. PMID: 38586683 Free PMC article.
Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer.
Repka MC, Sholklapper T, Zwart AL, Danner M, Ayoob M, Yung T, Lei S, Collins BT, Kumar D, Suy S, Hankins RA, Kishan AU, Collins SP. Repka MC, et al. Among authors: collins sp. Front Oncol. 2024 Mar 22;14:1381134. doi: 10.3389/fonc.2024.1381134. eCollection 2024. Front Oncol. 2024. PMID: 38585005 Free PMC article.
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial.
Tromp J, Kosiborod MN, Angermann CE, Collins SP, Teerlink JR, Ponikowski P, Biegus J, Ferreira JP, Nassif ME, Psotka MA, Brueckmann M, Blatchford JP, Steubl D, Voors AA. Tromp J, et al. Among authors: collins sp. Eur J Heart Fail. 2024 Apr 4. doi: 10.1002/ejhf.3218. Online ahead of print. Eur J Heart Fail. 2024. PMID: 38572654
Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure.
Cox ZL, Collins SP, Hernandez GA, McRae AT 3rd, Davidson BT, Adams K, Aaron M, Cunningham L, Jenkins CA, Lindsell CJ, Harrell FE Jr, Kampe C, Miller KF, Stubblefield WB, Lindenfeld J. Cox ZL, et al. Among authors: collins sp. J Am Coll Cardiol. 2024 Apr 9;83(14):1295-1306. doi: 10.1016/j.jacc.2024.02.009. J Am Coll Cardiol. 2024. PMID: 38569758 Clinical Trial.
662 results